Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$0.92 USD
-0.03 (-2.75%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.92 0.00 (-0.42%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for Oncolytics Biotech Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -20.56 | -19.10 | -20.99 | -16.80 | -24.96 |
Depreciation/Amortization & Depletion | 0.30 | 0.30 | 0.36 | 0.33 | 0.37 |
Net Change from Assets/Liabilities | 1.31 | 0.30 | -0.72 | 0.16 | -1.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -2.12 | 0.54 | 3.45 | -0.16 | 10.95 |
Net Cash From Operating Activities | -21.07 | -17.96 | -17.90 | -16.47 | -15.00 |
Property & Equipment | -0.01 | -0.04 | -0.23 | -0.02 | -0.01 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 14.99 | -15.65 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 14.98 | -15.69 | -0.23 | -0.02 | -0.01 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 15.82 | 0.00 | 0.18 | 1.27 | 10.05 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.30 | -0.29 | -0.29 | -0.34 | -0.34 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 8.18 | 9.68 | 26.45 | 28.77 | 6.13 |
Net Cash from Financing Activities | 23.70 | 9.39 | 26.34 | 29.69 | 15.84 |
Effect of Exchange Rate Changes | -0.39 | 1.51 | -0.20 | -0.45 | -0.49 |
Net Change In Cash & Equivalents | 17.22 | -22.77 | 8.01 | 12.74 | 0.34 |
Cash at Beginning of Period | 8.64 | 31.74 | 24.91 | 10.56 | 10.32 |
Cash at End of Period | 25.86 | 8.97 | 32.92 | 23.31 | 10.66 |
Diluted Net EPS | -0.30 | -0.33 | -0.39 | -0.42 | -1.13 |
Fiscal Year End for Oncolytics Biotech Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -10.34 | -5.11 | -20.56 | -17.74 | -10.32 |
Depreciation/Amortization & Depletion | 0.16 | 0.09 | 0.30 | 0.22 | 0.14 |
Net Change from Assets/Liabilities | 0.13 | -0.02 | 1.31 | 0.18 | -2.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -0.40 | -0.49 | -2.12 | 0.70 | 0.62 |
Net Cash From Operating Activities | -10.44 | -5.54 | -21.07 | -16.64 | -12.12 |
Property & Equipment | -0.15 | -0.03 | -0.01 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 14.99 | 15.08 | 10.01 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.15 | -0.03 | 14.98 | 15.07 | 10.01 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 15.82 | 15.92 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.12 | -0.08 | -0.30 | -0.23 | -0.15 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.66 | 1.18 | 8.18 | 6.85 | 6.82 |
Net Cash from Financing Activities | 2.54 | 1.11 | 23.70 | 22.55 | 6.67 |
Effect of Exchange Rate Changes | 0.70 | 0.53 | -0.39 | 0.12 | -0.20 |
Net Change In Cash & Equivalents | -7.35 | -3.94 | 17.22 | 21.10 | 4.35 |
Cash at Beginning of Period | 25.51 | 25.88 | 8.64 | 8.69 | 8.68 |
Cash at End of Period | 18.16 | 21.94 | 25.86 | 29.80 | 13.03 |
Diluted Net EPS | -0.07 | -0.07 | -0.03 | -0.11 | -0.09 |